Laser treatment for lipoatrophy in children with diabetes type 1

Area of Science:

• Endocrinology
• Dermatology
• Pediatrics

Background:

• Lipoatrophy (LA) is a rare complication of insulin therapy, particularly in patients with type 1 diabetes (T1DM).
• Despite advancements like insulin analogues, effective treatments for insulin-induced LA remain elusive.
• This condition affects subcutaneous fat tissue, leading to localized fat loss.

Observation:

• Two pediatric patients with T1DM presented with significant lipoatrophy.
• Previous treatments, including insulin regimen changes and topical therapies, yielded limited or no improvement.
• Lipoatrophy occurred in areas not directly associated with insulin administration sites in one case.

Findings:

• Both children experienced successful treatment of lipoatrophy using laser therapy.
• The first patient showed impressive improvement after laser treatment for LA.
• The second patient achieved a remarkable outcome with laser treatment following partial improvement from other interventions.

Implications:

• Laser treatment emerges as a potentially effective therapeutic option for insulin-induced lipoatrophy.
• This finding offers a novel approach for managing a challenging complication in pediatric T1DM patients.
• Further research is warranted to validate laser therapy's efficacy and safety for LA across broader populations.